Brainsway Stock Performance

BRSYF Stock  USD 11.54  0.00  0.00%   
On a scale of 0 to 100, BrainsWay holds a performance score of 12. The firm shows a Beta (market volatility) of 1.55, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BrainsWay will likely underperform. Please check BrainsWay's risk adjusted performance, variance, as well as the relationship between the Variance and skewness , to make a quick decision on whether BrainsWay's price patterns will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BrainsWay are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BrainsWay reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow17 M
Total Cashflows From Investing Activities-42.2 M
  

BrainsWay Relative Risk vs. Return Landscape

If you would invest  800.00  in BrainsWay on November 15, 2025 and sell it today you would earn a total of  354.00  from holding BrainsWay or generate 44.25% return on investment over 90 days. BrainsWay is currently producing 0.6857% returns and takes up 4.2259% volatility of returns over 90 trading days. Put another way, 37% of traded pink sheets are less volatile than BrainsWay, and 87% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon BrainsWay is expected to generate 5.44 times more return on investment than the market. However, the company is 5.44 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

BrainsWay Target Price Odds to finish over Current Price

The tendency of BrainsWay Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 11.54 90 days 11.54 
about 11.6
Based on a normal probability distribution, the odds of BrainsWay to move above the current price in 90 days from now is about 11.6 (This BrainsWay probability density function shows the probability of BrainsWay Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 1.55 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BrainsWay will likely underperform. Moreover BrainsWay has an alpha of 1.1968, implying that it can generate a 1.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   BrainsWay Price Density   
       Price  

Predictive Modules for BrainsWay

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BrainsWay. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BrainsWay's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
7.3111.5415.77
Details
Intrinsic
Valuation
LowRealHigh
8.3412.5716.80
Details

BrainsWay Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BrainsWay is not an exception. The market had few large corrections towards the BrainsWay's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BrainsWay, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BrainsWay within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.20
β
Beta against Dow Jones1.55
σ
Overall volatility
1.69
Ir
Information ratio 0.18

BrainsWay Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BrainsWay for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BrainsWay can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BrainsWay appears to be risky and price may revert if volatility continues
The company reported the revenue of 29.66 M. Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.
About 20.0% of the company shares are held by company insiders

BrainsWay Fundamentals Growth

BrainsWay Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of BrainsWay, and BrainsWay fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BrainsWay Pink Sheet performance.

About BrainsWay Performance

By analyzing BrainsWay's fundamental ratios, stakeholders can gain valuable insights into BrainsWay's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BrainsWay has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BrainsWay has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.

Things to note about BrainsWay performance evaluation

Checking the ongoing alerts about BrainsWay for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for BrainsWay help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BrainsWay appears to be risky and price may revert if volatility continues
The company reported the revenue of 29.66 M. Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.
About 20.0% of the company shares are held by company insiders
Evaluating BrainsWay's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BrainsWay's pink sheet performance include:
  • Analyzing BrainsWay's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BrainsWay's stock is overvalued or undervalued compared to its peers.
  • Examining BrainsWay's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BrainsWay's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BrainsWay's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of BrainsWay's pink sheet. These opinions can provide insight into BrainsWay's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BrainsWay's pink sheet performance is not an exact science, and many factors can impact BrainsWay's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for BrainsWay Pink Sheet analysis

When running BrainsWay's price analysis, check to measure BrainsWay's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrainsWay is operating at the current time. Most of BrainsWay's value examination focuses on studying past and present price action to predict the probability of BrainsWay's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrainsWay's price. Additionally, you may evaluate how the addition of BrainsWay to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities